Azevedo & Travassos S.A. (BVMF:AZEV3)

Verve Therapeutics Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.93	3.15	2.09	11.67	19.34	4.58
Cash & Short-Term Investments	10.93	3.15	2.09	11.67	19.34	4.58
Cash Growth	822.53%	50.77%	-82.09%	-39.65%	321.97%	9863.04%
Accounts Receivable	85.62	66.82	79.46	89.68	33.97	2.36
Other Receivables	36.88	30.49	31.76	28.86	11.09	11.8
Receivables	122.49	97.3	111.22	118.54	45.07	14.16
Inventory	18.27	17.67	24.31	43.21	37.37	19.26
Prepaid Expenses	1.33	0.87	2.2	3.77	0.49	0
Other Current Assets	10.81	7.07	16.81	2.19	15.25	1.71
Total Current Assets	163.83	126.06	156.64	179.37	117.53	39.71
Property, Plant & Equipment	55.24	69.85	242.63	79.97	60.59	14.34
Long-Term Investments	751	-	-	-	-	-
Other Intangible Assets	108.92	260.88	139.21	166.18	199.5	0.02
Long-Term Deferred Tax Assets	175.15	190.55	114.31	74.95	-	-
Other Long-Term Assets	58.81	40.9	71.69	46.37	41.49	9.64
Total Assets	1,313	688.23	724.48	546.84	419.11	63.72
Accounts Payable	103.97	88.56	73.74	39.84	27.64	19.25
Accrued Expenses	142.87	137.25	206.91	100.57	42.81	46.88
Short-Term Debt	96.77	66.55	3.73	-	-	-
Current Portion of Long-Term Debt	9.13	3.26	25.58	33.87	19.01	22.7
Current Portion of Leases	4.09	5.55	0.5	16.97	-	-
Current Income Taxes Payable	2.79	0.38	0.35	-	0.44	64.84
Other Current Liabilities	9.2	12.32	7.2	36.97	7.89	4.03
Total Current Liabilities	368.81	313.86	318.02	228.22	97.78	157.69
Long-Term Debt	4.63	2.67	8.35	9.66	-	-
Long-Term Leases	29.46	31.42	0.94	6.8	-	-
Long-Term Deferred Tax Liabilities	3.45	1.49	6.1	32.13	29.59	-
Other Long-Term Liabilities	188.11	202.42	73.96	173.03	184.76	146.04
Total Liabilities	594.46	551.85	407.36	449.84	312.14	303.74
Common Stock	1,209	651.19	565.44	294.52	224.52	71.25
Retained Earnings	-490.5	-514.81	-248.32	-197.52	-117.55	-318.23
Comprehensive Income & Other	-	-	-	-	-	6.96
Total Common Equity	718.48	136.38	317.12	97	106.97	-240.01
Shareholders' Equity	718.48	136.38	317.12	97	106.97	-240.01
Total Liabilities & Equity	1,313	688.23	724.48	546.84	419.11	63.72
Total Debt	144.08	109.45	39.1	67.3	19.01	22.7
Net Cash (Debt)	-133.15	-106.3	-37.01	-55.63	0.33	-18.11
Net Cash Per Share	-0.22	-0.54	-0.22	-0.72	0.01	-0.91
Filing Date Shares Outstanding	592.75	197.59	167.81	77.18	54.45	19.8
Total Common Shares Outstanding	592.75	197.59	167.81	77.18	54.45	19.8
Working Capital	-204.98	-187.8	-161.38	-48.85	19.74	-117.98
Book Value Per Share	1.21	0.69	1.89	1.26	1.96	-12.12
Tangible Book Value	609.56	-124.5	177.91	-69.18	-92.53	-240.04
Tangible Book Value Per Share	1.03	-0.63	1.06	-0.90	-1.70	-12.12
Land	-	-	219.47	34.09	34.09	8.34
Buildings	-	-	-	-	-	6.57
Machinery	21.73	34.91	35.7	35.68	27.6	17.38
Construction In Progress	-	-	-	-	0.03	-
Leasehold Improvements	0.11	0.24	0.24	0.24	-	-
Order Backlog	-	745	-	-	380	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.